Abpro Holdings, Inc. (ABPWW)
- Previous Close
0.0205 - Open
0.0222 - Bid --
- Ask --
- Day's Range
0.0222 - 0.0222 - 52 Week Range
0.0222 - 0.0222 - Volume
824 - Avg. Volume
-- - Market Cap (intraday)
-- - Beta (5Y Monthly) -0.08
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Abpro Holdings, Inc., a biotechnology company, provides antibody therapeutics for cancer related issues. Its platform DiversImmune addresses the antibody therapeutics. The company's product candidates include ABP-102 for the treatment of breast and gastric cancer; and ABP-110 for the treatment of liver cancer. It also offers ABP-105 for the treatment of gastric cancer and ABP 201 for vascular diseases of the eye and diabetic macular edema. Abpro Holdings, Inc. was incorporated in 2004 and is based in Woburn, Massachusetts.
abpro.comRecent News: ABPWW
View MoreCompare To: ABPWW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ABPWW
View MoreValuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-154.71%
Return on Equity (ttm)
--
Revenue (ttm)
183k
Net Income Avi to Common (ttm)
-17.41M
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
2.85M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-525.5k